Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Macor

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Neuroimmunology|August 1, 1991
CD21+ (B2 antigen+) cell decrement and CD4+CD29+ (helper-inducer) cell increment suggest an activation of cell immune reactivity in multiple sclerosisD Gambi, A M Porrini, A Giampietro, et al.
Acta Neurologica|December 1, 1991
Multiple sclerosis: an immune system activation diseaseS Macor, A M Porrini, A Giampietro, et al.
Folia Endocrinologica|June 1, 1974
[Evaluation of the potential gonadotropin reserve with specific stimulation with "releasing hormone"]A Benedetti, G C Englaro, F Di Chiara, et al.
FEBS Letters|August 7, 1999
Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritisR M Borzi, I Mazzetti, S Macor, et al.
International Journal of Oncology|December 15, 2000
Human osteosarcoma cells release matrix degrading enzymes in response to chemokine activationS Paoletti, R M Borzi, I Mazzetti, et al.
European Journal of Clinical Pharmacology|September 29, 1999
Lowering effects of four different statins on serum triglyceride levelA Branchi, A M Fiorenza, A Rovellini, et al.
Journal of the Neurological Sciences|May 1, 1991
Amplifications of multiple regions of the HTLV-I genome from DNA of an Italian spastic paraparesis patient but not from DNA of multiple sclerosis patientsD French, S Mammarella, M C Curia, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Neuroimmunology|August 1, 1991
CD21+ (B2 antigen+) cell decrement and CD4+CD29+ (helper-inducer) cell increment suggest an activation of cell immune reactivity in multiple sclerosisD Gambi, A M Porrini, A Giampietro, et al.
Acta Neurologica|December 1, 1991
Multiple sclerosis: an immune system activation diseaseS Macor, A M Porrini, A Giampietro, et al.
Folia Endocrinologica|June 1, 1974
[Evaluation of the potential gonadotropin reserve with specific stimulation with "releasing hormone"]A Benedetti, G C Englaro, F Di Chiara, et al.
FEBS Letters|August 7, 1999
Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritisR M Borzi, I Mazzetti, S Macor, et al.
International Journal of Oncology|December 15, 2000
Human osteosarcoma cells release matrix degrading enzymes in response to chemokine activationS Paoletti, R M Borzi, I Mazzetti, et al.
European Journal of Clinical Pharmacology|September 29, 1999
Lowering effects of four different statins on serum triglyceride levelA Branchi, A M Fiorenza, A Rovellini, et al.
Journal of the Neurological Sciences|May 1, 1991
Amplifications of multiple regions of the HTLV-I genome from DNA of an Italian spastic paraparesis patient but not from DNA of multiple sclerosis patientsD French, S Mammarella, M C Curia, et al.
Pageof 1